Company has impaired Vemgal by Rs 1.19 billion to reflect the estimated realisable value of Rs 1.8 billion at which it is being sold to Hetero. Hence, reported PAT declined 89.6% y-o-y. Adjusting for it PAT fell 20.0% y-o-y t
We expect this trend in recovery in the acute therapies to continue in the coming quarters. GSKP’s exposure only to domestic formulations, strong balance sheet and strong brand equity augurs well. Maintain ADD with a revise
Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker GlaxoSmithKline posted a loss of ₤428 million for the fourth quarter of 2015 compared with a pro
Glenmark obtains semi-exclusive marketing and distribution rights for the product across 15 European countries, including Great Britain and Germany upon commercialisation Glenmark Pharmaceuticals Europe has entered into a str
Drugmaker GlaxoSmithKline , which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania.
Fortune magazine has announced its list of 2015 ‘World’s Most Admired Companies.’ The companies on the world’s most admired list were rated based on nine key attributes, including innovativeness, sound financi